E-PaperDivis Laboratories Q3 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
4,518.95
-63.35 (-1.38%)
-63.35 (-1.38%)Volume5.52 K
Updated: Fri 19 Jul, 2024 | 15:29:07
NSE
4,519.8-65.00 (-1.42%)
-65.00 (-1.42%)Volume2.79 L
Updated: Fri 19 Jul, 2024 | 15:58:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Divis Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,855.00 | 1,909.00 | -2.83% | 1,707.68 | 8.63% |
| Selling/ General/ Admin Expenses Total | 268.00 | 266.00 | 0.75% | 238.88 | 12.19% |
| Depreciation/ Amortization | 95.00 | 95.00 | 0.00% | 86.77 | 9.48% |
| Other Operating Expenses Total | 369.00 | 354.00 | 4.24% | 320.97 | 14.96% |
| Total Operating Expense | 1,461.00 | 1,525.00 | -4.20% | 1,386.17 | 5.40% |
| Operating Income | 394.00 | 384.00 | 2.60% | 321.51 | 22.55% |
| Net Income Before Taxes | 489.00 | 469.00 | 4.26% | 435.63 | 12.25% |
| Net Income | 358.00 | 348.00 | 2.87% | 306.80 | 16.69% |
| Diluted Normalized EPS | 13.50 | 13.11 | 2.97% | 11.56 | 16.78% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Buy or sell: Sumeet Bagadia recommends these three stocks to buy on Monday — July 22
4 min read10:11 AM IST - Markets
02Sanstar Limited IPO: GMP jumps after strong subscription status. Apply or not?
3 min read06:54 AM IST - Markets
03Gold and silver prices today on 21-07-2024: Check latest rates in your city
2 min read10:15 AM IST